Cancer treatment advancements took center stage this week. AI systems like Gemini improved colorectal cancer analysis and lung cancer predictions by studying medical images. Apple’s unreleased Health+ assistant and tools like Abridge automatically summarize doctor-patient conversations, saving clinicians hours weekly.

Virtual assistants led AI healthcare growth, handling tasks like appointment booking and medication alerts. Over 70% of U.S. healthcare groups using AI reported success, though costs and unclear regulations slowed wider adoption.

New diagnostic tools emerged globally. Cambridge researchers trained AI on 4,000+ images to diagnose celiac disease as accurately as pathologists. In New York, ScopeAI began offering free care to ride-share drivers through a labor partnership, with plans to expand.

Child-focused AI made waves. A study at ESCMID will show how AI improves antibiotic dosing accuracy for kids, addressing unique challenges in pediatric care. Another tool reduced acute kidney injury risks by optimizing drug levels, crucial for patient safety.

Regulators pushed for responsible AI use. California’s AB 489 bill seeks to ban companies from marketing AI chatbots as licensed doctors, ensuring humans remain in charge. Meanwhile, India’s government and private startups are rolling out AI for low-cost diagnostics, while China prioritizes AI in its national health plans.

Doctors shared real-world experiences—AI charting tools saved time but sometimes struggled with complex cases. Pharmacists praised AI for flagging dangerous drug interactions, though they stressed final decisions must stay human-led.

Global markets reflected these trends, with the AI healthcare sector projected to hit $613 billion by 2034. Machine learning dominated the tech stack, powering everything from medical imaging to hospital workflows.

Challenges persist, including data privacy concerns and uneven access in rural areas. However, tools like Leapfrog Group’s AI alerts for patient risks show promise in preventing errors, hinting at a safer future.